Editas Medicine, Inc. SEC filings EDIT

Editas Medicine, Inc. has 727 filings in SEC EDGAR's recent list, going back to Aug 18, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Apr 28, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Editas Medicine, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 8, 2026 Oct 8, 2026
S-8 Employee stock plan registration Sep 9, 2026 —
EFFECT Filing Sep 8, 2026 —
S-3 Shelf registration Aug 31, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change
Aug 5, 2026 Aug 3, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
424B5 Prospectus supplement May 26, 2026 —
8-K Current report
Material agreement, Other events
May 26, 2026 May 26, 2026
S-3MEF Filing May 26, 2026 —
8-K Current report
Other events
May 26, 2026 May 26, 2026
424B5 Prospectus supplement May 26, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 26, 2026 May 25, 2026
8-K Current report
Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 28, 2026 Apr 28, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Apr 28, 2026
8-K Current report
Auditor change
Apr 7, 2026 Apr 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 27, 2026 Mar 26, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 9, 2026 Mar 9, 2026
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 9, 2025 Oct 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 2, 2025 Sep 2, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 12, 2025 Jun 12, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 2, 2025 May 29, 2025
8-K Current report
Regulation FD disclosure, Other events
May 14, 2025 May 14, 2025
8-K Current report
Regulation FD disclosure, Other events
May 13, 2025 May 13, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 15, 2025 Apr 15, 2025
DEFA14A Additional proxy material Apr 15, 2025 —
DEF 14A Proxy statement Apr 15, 2025 Apr 15, 2025
PRE 14A Preliminary proxy statement Apr 4, 2025 Apr 4, 2025
EFFECT Filing Mar 21, 2025 —
8-K Current report
Officer or director change
Mar 20, 2025 Mar 18, 2025
POS AM Filing Mar 5, 2025 —
S-8 Employee stock plan registration Mar 5, 2025 —
10-K Annual report Mar 5, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 5, 2025 Mar 5, 2025
POSASR Filing Mar 5, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Dec 17, 2024 Dec 16, 2024
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
Dec 12, 2024 Dec 11, 2024
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Dec 10, 2024 Dec 6, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 22, 2024 Oct 22, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Oct 4, 2024 Oct 3, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change
Jun 27, 2024 Jun 27, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 14, 2024 Jun 14, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 30, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
DEFA14A Additional proxy material Apr 16, 2024 —
DEF 14A Proxy statement Apr 16, 2024 Apr 16, 2024
S-3ASR Automatic shelf registration Feb 28, 2024 —
S-8 Employee stock plan registration Feb 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 13, 2023 Dec 12, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 11, 2023 Dec 11, 2023
8-K Current report
Officer or director change
Nov 22, 2023 Nov 16, 2023
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 3, 2023 Nov 3, 2023
8-K Current report
Officer or director change
Oct 10, 2023 Oct 3, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Material agreement, Other events
Jun 15, 2023 Jun 14, 2023
424B5 Prospectus supplement Jun 15, 2023 —
424B5 Prospectus supplement Jun 14, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Jun 9, 2023 Jun 9, 2023
8-K Current report
Shareholder vote results
Jun 5, 2023 Jun 1, 2023
8-K Current report
Officer or director change
May 17, 2023 May 11, 2023
10-Q Quarterly report May 5, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 5, 2023 May 5, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 18, 2023 —
DEF 14A Proxy statement Apr 18, 2023 —
8-K Current report
Officer or director change
Apr 13, 2023 Apr 11, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 14, 2023 Mar 8, 2023
S-8 Employee stock plan registration Feb 22, 2023 —
10-K Annual report Feb 22, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Officer or director change
Jan 9, 2023 Jan 7, 2023
8-K Current report
Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Other events
Nov 17, 2022 Nov 17, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Shareholder vote results
Jun 13, 2022 Jun 9, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 9, 2022
8-K Current report
Officer or director change
Apr 14, 2022 Apr 12, 2022
S-8 Employee stock plan registration Feb 24, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Officer or director change
Feb 7, 2022 Feb 7, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Officer or director change
Oct 28, 2021 Oct 26, 2021
CT ORDER Filing Oct 15, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Sep 29, 2021 Sep 29, 2021
8-K Current report
Officer or director change
Sep 8, 2021 Sep 3, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
CT ORDER Filing Jul 13, 2021 —
8-K Current report
Shareholder vote results
Jun 8, 2021 Jun 3, 2021
DEFA14A Additional proxy material May 21, 2021 —
8-K Current report
Material agreement
May 14, 2021 May 14, 2021
424B5 Prospectus supplement May 14, 2021 —
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 20, 2021 —
DEF 14A Proxy statement Apr 20, 2021 Jun 3, 2021
SEC STAFF LETTER Filing Mar 23, 2021 —
S-8 Employee stock plan registration Mar 1, 2021 —
S-3ASR Automatic shelf registration Mar 1, 2021 —
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
SEC STAFF LETTER Filing Feb 23, 2021 —
8-K/A Amended current report
Officer or director change
Feb 19, 2021 Feb 4, 2021
8-K Current report
Officer or director change
Feb 8, 2021 Feb 4, 2021
8-K Current report
Material agreement, Other events
Jan 21, 2021 Jan 20, 2021
424B5 Prospectus supplement Jan 21, 2021 —
8-K Current report
Results of operations, Other events
Jan 19, 2021 Jan 19, 2021
424B5 Prospectus supplement Jan 19, 2021 —
8-K Current report
Officer or director change, Other events
Jan 11, 2021 Jan 5, 2021
424B7 Filing Jan 11, 2021 —
8-K Current report
Officer or director change
Dec 18, 2020 Dec 17, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Material agreement, Agreement ended, Results of operations
Aug 6, 2020 Aug 5, 2020
8-K Current report
Material agreement, Other events
Jun 25, 2020 Jun 23, 2020
424B5 Prospectus supplement Jun 25, 2020 —
S-3ASR Automatic shelf registration Jun 23, 2020 —
8-K Current report
Shareholder vote results
Jun 15, 2020 Jun 10, 2020
424B5 Prospectus supplement May 15, 2020 —
8-K Current report
Material agreement
May 15, 2020 May 15, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
8-K Current report
Officer or director change
May 6, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 28, 2020 —
DEF 14A Proxy statement Apr 28, 2020 Jun 10, 2020
CT ORDER Filing Apr 27, 2020 —
S-8 Employee stock plan registration Feb 26, 2020 —
10-K Annual report Feb 26, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 26, 2020 Feb 26, 2020
8-K Current report
Officer or director change
Jan 10, 2020 Jan 9, 2020
CT ORDER Filing Dec 26, 2019 —
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
CT ORDER Filing Oct 24, 2019 —
8-K Current report
Officer or director change
Sep 30, 2019 Sep 26, 2019
SEC STAFF LETTER Filing Sep 26, 2019 —
SEC STAFF LETTER Filing Sep 23, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2019 Jun 12, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEFA14A Additional proxy material Apr 26, 2019 —
DEF 14A Proxy statement Apr 26, 2019 Jun 12, 2019
S-8 Employee stock plan registration Mar 14, 2019 —
10-K Annual report Mar 1, 2019 Dec 31, 2018
8-K Current report
Material agreement, Results of operations
Feb 28, 2019 Feb 22, 2019
8-K Current report
Officer or director change
Feb 7, 2019 Feb 5, 2019
8-K Current report
Officer or director change
Jan 22, 2019 Jan 18, 2019
8-K Current report
Officer or director change
Dec 21, 2018 Dec 18, 2018
8-K Current report
Officer or director change
Dec 10, 2018 Dec 6, 2018
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
CT ORDER Filing Oct 25, 2018 —
10-Q/A Amended quarterly report Oct 23, 2018 Jun 30, 2018
CT ORDER Filing Oct 18, 2018 —
CT ORDER Filing Oct 18, 2018 —
CT ORDER Filing Oct 18, 2018 —
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Results of operations, Other events
Aug 6, 2018 Aug 6, 2018
8-K Current report
Shareholder vote results
Jun 19, 2018 Jun 15, 2018
8-K Current report
Other events
Jun 8, 2018 Jun 8, 2018
424B7 Filing Jun 8, 2018 —
8-K Current report
Material agreement, New debt
Jun 8, 2018 Jun 7, 2018
10-Q Quarterly report May 4, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 3, 2018 May 3, 2018
DEFA14A Additional proxy material Apr 27, 2018 —
DEF 14A Proxy statement Apr 27, 2018 Jun 15, 2018
8-K Current report
Officer or director change
Mar 28, 2018 Mar 27, 2018
S-3ASR Automatic shelf registration Mar 12, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
EDIT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1650664

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.